|
|
Volumn 376, Issue 9757, 2010, Pages 1984-1985
|
|
Termination of the CRESCENDO trial - Authors' reply
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
RIMONABANT;
ANTIOBESITY AGENT;
CARDIOVASCULAR AGENT;
CYTOCHROME P450 2D6;
PIPERIDINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
BARIATRIC SURGERY;
CARDIOVASCULAR DISEASE;
DRUG MARKETING;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
LETTER;
MORTALITY;
NEUROPSYCHIATRY;
OBESITY;
PATIENT SAFETY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STROKE;
SUICIDE;
DEPRESSION;
EUROPE;
GENETICS;
METABOLISM;
METHODOLOGY;
MULTICENTER STUDY (TOPIC);
NOTE;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STATISTICS;
TREATMENT FAILURE;
ANTI-OBESITY AGENTS;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
CYTOCHROME P-450 CYP2D6;
DEPRESSIVE DISORDER;
EUROPE;
HUMANS;
MULTICENTER STUDIES AS TOPIC;
PIPERIDINES;
PYRAZOLES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
SUICIDE;
TREATMENT FAILURE;
|
|
EID: 78650163962
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)62256-8 Document Type: Letter |
|
Times cited : (2)
|
|
References (3)
|
